BlackRock Investment Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.45M | Sell |
27,253
-299
| -1% | -$15.9K | ﹤0.01% | 2439 |
|
|
2016
Q3 | $1.67M | Sell |
27,552
-196
| -0.7% | -$11.9K | ﹤0.01% | 2296 |
|
|
2016
Q2 | $1.83M | Buy |
27,748
+4,739
| +21% | +$312K | ﹤0.01% | 2174 |
|
|
2016
Q1 | $1.31M | Buy |
23,009
+801
| +4% | +$45.4K | ﹤0.01% | 2302 |
|
|
2015
Q4 | $5.22M | Buy |
22,208
+96
| +0.4% | +$22.6K | 0.01% | 1364 |
|
|
2015
Q3 | $3.5M | Sell |
22,112
-1,225
| -5% | -$194K | ﹤0.01% | 1635 |
|
|
2015
Q2 | $8.83M | Buy |
23,337
+3,669
| +19% | +$1.39M | 0.01% | 1081 |
|
|
2015
Q1 | $8.22M | Buy |
19,668
+1,825
| +10% | +$763K | 0.01% | 1062 |
|
|
2014
Q4 | $4.88M | Sell |
17,843
-184
| -1% | -$50.4K | 0.01% | 1371 |
|
|
2014
Q3 | $3.5M | Buy |
18,027
+68
| +0.4% | +$13.2K | ﹤0.01% | 1593 |
|
|
2014
Q2 | $4.4M | Buy |
17,959
+1,296
| +8% | +$317K | 0.01% | 1484 |
|
|
2014
Q1 | $4.42M | Buy |
16,663
+117
| +0.7% | +$31K | 0.01% | 1449 |
|
|
2013
Q4 | $6.01M | Buy |
16,546
+1,135
| +7% | +$412K | 0.01% | 1218 |
|
|
2013
Q3 | $8.19M | Buy |
15,411
+816
| +6% | +$434K | 0.01% | 962 |
|
|
2013
Q2 | $3.42M | Buy |
+14,595
| New | +$3.42M | 0.01% | 1467 |
|